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MicroRNAs (miRNAs) regulate various biological
processes, but evidence for miRNAs that control
the differentiation program of specific neural cell
types has been elusive. To determine the role of
miRNAs in the formation of myelinating oligodendro-
cytes, we selectively deleted a miRNA-processing
enzyme, Dicer1, in oligodendrocyte lineage cells.
Mice lacking Dicer1 display severe myelinating defi-
cits despite an expansion of the oligodendrocyte
progenitor pool. To search for miRNAs responsible
for the induction of oligodendrocyte maturation, we
identified miR-219 and miR-338 as oligodendro-
cyte-specific miRNAs in spinal cord. Overexpression
of these miRNAs is sufficient to promote oligoden-
drocyte differentiation. Additionally, blockage of
these miRNA activities in oligodendrocyte precursor
culture and knockdown of miR-219 in zebrafish
inhibit oligodendrocyte maturation. miR-219 and
miR-338 function in part by directly repressing nega-
tive regulators of oligodendrocyte differentiation,
including transcription factors Sox6 and Hes5. These
findings illustrate that miRNAs are important regula-
tors of oligodendrocyte differentiation, providing
new targets for myelin repair.
INTRODUCTION
Oligodendrocytes, a fundamental and unique cell type in the
CNS, synthesize multilamellar myelin membranes that ensheath
axons. They play a critical role for development and function of
the CNS. Failure of remyelination by oligodendrocytes disrupts
saltatory nerve conduction, leading to nerve degeneration asso-
ciated with acquired and inherited disorders such as multiple
sclerosis (MS) and leukodystrophies (Berger et al., 2001; Trapp612 Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc.et al., 1998). At present, molecular mechanisms controlling
oligodendrocyte differentiation and myelination are poorly
understood.
Myelinating oligodendrocytes are derived from multipotent
neural progenitor cells. Numerous signaling pathways such as
Shh, Wnt, Bmp, and Notch, appear to regulate oligodendrocyte
specification and differentiation (Miller, 2002; Rowitch, 2004).
Such pathways often modulate transcriptional events via
either DNA-binding transcription factors or chromatin-remodel-
ing factors to dictate oligodendrocyte formation (Copray et al.,
2009; Shen and Casaccia-Bonnefil, 2008). As a result, transcrip-
tional regulation of oligodendrocyte lineage development has
been a major focus in understanding mechanisms promoting
differentiation of oligodendrocyte precursor cells (OPCs). A
balance in the activity of transcriptional activators and repres-
sors controls the formation of myelinating oligodendrocytes in
a spatially and temporally specific manner (Emery et al., 2009;
Rowitch, 2004; Wegner, 2008; Ye et al., 2009).
In addition to transcriptional regulation, posttranscriptional
control by small noncoding RNAs has emerged as a central
regulator of many biological and disease processes such as
cell proliferation, differentiation, apoptosis, stress response,
and tumorigenesis (reviewed in Bartel, 2004; Stefani and Slack,
2008). miRNAs are a class of small noncoding RNAs (22 nt)
that negatively regulate gene expression posttranscriptionally,
either through translational inhibition or degradation of target
mRNAs (Flynt and Lai, 2008; Hobert, 2004). miRNAs are initially
transcribed as long primary transcripts (pri-miRNAs) and cleaved
first by a nuclear RNase enzyme complex, Drosha/DGCR8. After
being exported into the cytoplasm mediated by exportin 5, they
are processed by a RNase-III-type enzyme Dicer to form mature
miRNAs, which are then incorporated into the RNA-induced
silencing complex (RISC) to direct posttranscriptional repression
(Bartel, 2004; Stefani and Slack, 2008). A short sequence
complementarity between the ‘‘seed’’ sequence in 50 miRNAs
and the 30 untranslated region (30 UTR) of mRNA targets is an
important determinant of miRNA targeting, rendering the ability
of a miRNA to potentially regulate multiple target genes simulta-
neously and shape transcriptional networks (Bartel, 2009).
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2009; Kawase-Koga et al., 2009; Leucht et al., 2008; Visvanathan
et al., 2007), we hypothesized that oligodendroglial lineage
specification and differentiation might be guided at least in part
by a posttranscriptional mechanism of gene regulation, namely
by miRNAs. In this study, we deleted Dicer1, an enzyme essen-
tial for the biogenesis of most miRNAs, in the oligodendrocyte
lineage cells, and observed severe myelination deficits in the
Dicer1 mutants. By miRNA profiling, we identified a cohort of
miRNAs reduced in the Dicer1 mutants. Among them, miR-219
and miR-338 are specifically expressed in oligodendrocytes
and their expression is significantly downregulated in myelin-
deficient Dicer1 or Olig1 mutants. Through gain- and loss-of-
function experiments in vitro and in vivo, we demonstrated
that miR-219 and miR-338 positively regulate oligodendrocyte
differentiation. Furthermore, we showed that miR-219 and
miR-338 control oligodendrogenesis by directly targeting nega-
tive regulators of oligodendrocyte differentiation such as Hes5
and Sox6, while inhibiting genes involved in neuronal differentia-
tion. Our present study provides insight into the regulation of
oligodendrocyte differentiation and myelination by miRNAs.
This study further suggests that repression of oligodendrocyte
differentiation inhibitors by miRNAs is a critical mechanism for
the generation of terminally differentiated oligodendrocytes.
RESULTS
Deletion of Dicer1 in the Oligodendrocyte Lineage
Impairs Myelination
To assess the role of Dicer1 in oligodendrocyte development
in vivo, we selectively deleted Dicer1 in the oligodendrocyte
lineage by crossing Dicer1lox/lox mice with an Olig1-Cre line.
Olig1-promoter activity has been shown to direct Cre expression
in the oligodendrocyte lineage cells, including OPCs and mature
myelinating oligodendrocytes in the CNS (Lu et al., 2002; Ye
et al., 2009). The resulting Dicer1lox/lox;Olig1-Cre+/ mice
(referred to as Dicer1CKO) were born at Mendelian ratio but
developed severe tremor and ataxia, reminiscent of myelin-
deficient mice, and died around postnatal week 3.
Immunohistochemistry and in situ hybridization analysis of
Dicer1CKO mice revealed that expression of mature oligoden-
drocyte markers, myelin basic protein (MBP), CC1, and Plp1
encoding proteolipid protein, was essentially diminished in the
spinal cord and brain (Figures 1A and 1B). We did not detect a
substantial alteration in expression of an astrocyte marker
GFAP (Figure 1B) or a neuronal marker NeuN (data not shown)
in the mutant cortex.
Myelination deficits were further confirmed by electron
microscopy in the spinal cord and the optic nerve of Dicer1
mutants. The number of myelinated axons at P14 was reduced
significantly in the spinal cord and essentially absent in the optic
nerve (Figures 1C and 1D). The few myelinated axons observed
in the Dicer1CKO spinal cord were characterized by thinner
myelin sheaths. Severe myelination deficiency in Dicer1 mutants
suggests that maturation of miRNAs processed by Dicer1 is
required for oligodendrocyte differentiation and myelination.
The oligodendrocyte-specific deletion of the floxed Dicer1 allele
by Olig1-Cre was verified by quantitative real-time RT-PCR(qRT-PCR) using primers specific to the floxed exon 23 and
RNAs isolated from intact optic nerves, which are enriched
with oligodendrocytes (Figure 1E).
The dysmyelinating phenotype detected in Dicer1CKO mice
could be due to increased cell death, inhibited proliferation,
and/or arrested differentiation. In the CNS of Dicer1CKO mice,
we did not detect any significant increase of apoptotic cells by
examining the presence of activated caspase 3 and by TUNEL
assay (data not shown). To examine the fate of OPCs, we per-
formed BrdU pulse-labeling experiments and analyzed OPC
proliferation. In the developing cortex of Dicer1CKO mice, we
observed an increase of BrdU+ and Olig2+ cells (Figures 2A,
2B, 2E, and 2F). A majority of Olig2+ cells are PDGFRa-positive
(Figure 2C) at perinatal stages, and essentially all BrdU+ cycling
cells are PDGFRa-expressing OPCs (Figure 2D), but not neurons
or astrocytes (data not shown). Cycling OPCs (Brdu+/Olig2+)
were significantly increased in the cortex (Figure 2G). These
observations suggest that OPCs with Dicer1 deletion undergo
extensive proliferation without further differentiation into mature
oligodendrocytes.
Identification of miR-219 and miR-338
as Oligodendrocyte-Specific miRNAs
In light of the requirement of miRNA maturation for oligodendro-
cyte differentiation, we searched for miRNAs that are respon-
sible for oligodendrocyte maturation. We screened for miRNAs
downregulated in the spinal cord of dysmyelinating Dicer1CKO
mice by using miRNA microarray analysis. The optic nerve and
spinal cord tissues of myelin-deficient Olig1 null mice (Xin
et al., 2005) were included for analysis because Dicer1 deletion
may block the majority of, if not all, miRNA maturation. Among
those miRNAs downregulated in both Dicer1 and Olig1 mutants,
expression of miR-219 and miR-338 was the most significantly
reduced compared to wild-type (Figures 3A–3C and Table S1).
This is in keeping with previous data showing that these two
miRNAs are highly enriched in mature oligodendrocytes (Lau
et al., 2008). Northern blot analysis confirmed that both miR-219
and miR-338 were essentially absent in the spinal cord of Olig1
null or Dicer1CKO mice (Figure 3D; data not shown).
qRT-PCR analysis of the time course of miR-219 and miR-338
expression indicated that expression of these miRNAs increased
during spinal cord development (Figures 3E and 3F). A sharp
increase of miR-219 and miR-338 at perinatal stages coincides
with the onset of oligodendrocyte maturation at these stages
(Figures 3E and 3F). Consistently, expression ofDicer1 increases
during differentiation of OPCs into mature oligodendrocytes
(Figure S1). To determine the cell-type specificity of miR-219
and miR-338, we carried out in situ hybridization in the P14 spinal
cord using fluorescein-labeled miRNA probes that targeted to
the mature form of miRNAs. miR-219- and miR-338-positive
cells were detected mainly in the white matter of spinal cord
(Figure 3G). In contrast to the specific expression pattern of
miR-219 and miR-338 in the spinal white matter, scrambled
control probe did not detect any specific signal (data not shown).
Consistently, expression of these two miRNAs was undetectable
in the P14 spinal cord of Olig1 null mice, where there is a specific
loss of mature myelinating oligodendrocytes (Figure 3G).
Furthermore, we demonstrated that miR-219 and miR-338Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc. 613
Figure 1. Dicer1 Is Required for Oligodendrocyte Myelination
(A and B) Immunocytochemistry using antibodies to mature oligodendrocyte makers (MBP and CC1), an astrocyte marker GFAP, and in situ hybridization using
probes to Plp1 on frozen sections of P14 spinal cord and brains from control (Ctrl, Olig1Cre+/;Dicer1lox/+) and Dicer1CKO (Olig1Cre+/;Dicer1lox/lox) mice.
Expression of MBP, CC1, and Plp1 is evident in white matter (arrows) of Ctrl but not Dicer1CKO mice.
(C) Electron micrographs of spinal cord and optic nerves from Ctrl and Dicer1CKO mice at P14. Multilamellar myelin sheaths are apparent around many axons
in Ctrl mice, and axons in Dicer1CKO mice are essentially unmyelinated (red arrow).
(D) Histogram depicts quantification of myelinated axons in the optic nerve and spinal cord of Ctrl and Dicer1CKO mice per defined area (100 mm2), respectively
(n = 5).
(E) Histogram shows the qRT-PCR analysis of Dicer1 expression from RNAs isolated from intact optic nerves of Dicer1lox/+;Olig1Cre (Ctrl) and Dicer1CKO mice
(n = 3) at p14 with primers against the floxed exon at the Dicer1 locus. GAPDH was used as internal control.
Data represented as mean ± SEM. *p < 0.01 (Student’s t test). Scale bars in (A) and (B), 200 mm; in (C), 5 mm for upper panel and 2 mm for lower panel.
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(Figures 3H and 3I), but not with a neuronal maker NeuN (data
not shown). These data suggest that miR-219 and miR-338 are
specifically expressed in oligodendrocytes in the spinal cord.
miR-219 and miR-338 Promote OPC Maturation In Vitro
To examine the role of these miRNAs in oligodendrocyte differ-
entiation, we first transfected oligodendrocyte precursor-en-
riched cultures (Chen et al., 2007) with miR-219 and miR-338
mimics individually or together. Four days after treatment, the
cells were subjected to immunostaining for stage-specific oligo-
dendrocyte markers. Enforced expression of miR-219, miR-338,
or both resulted in a significant increase in the number of early
differentiated RIP+ oligodendrocytes and mature MBP+ oligo-614 Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc.dendrocytes (Figures 4A–4D). A slight reduction of PDGFRa-
expressing OPCs was observed after treatment of both miRNA
mimics (Figures 4B and 4E). These results suggest that enforced
miR-219 and miR-338 expression promotes oligodendrocyte
differentiation from their precursors.
To further determine whether overexpression of miR-219 and
miR-338 could rescue the defects of oligodendrocyte differenti-
ation due to Dicer1 deletion, we transfected primary oligoden-
drocyte progenitor-enriched culture isolated from Dicer1CKO
embryos with miR-219 or miR-338 mimics. In contrast to the
treatment of scrambled control, miR-219 or miR-338 mimics
could enhance oligodendrocyte maturation and increase the
number of mature MBP+ oligodendrocytes with complex
morphologies (Figures 4F and 4G). This result suggests that
Figure 2. Oligodendrocyte Precursor Proliferation in the Cortex of Dicer1 Mutants
(A–C) Immunocytochemistry using antibodies to Olig2, BrdU, and PDGFRa on frozen sections of P7 (B) and P14 (A–C) brains from Olig1Cre;Dicer1lox/+ (Ctrl) and
Olig1Cre;Dicer1lox/lox (Dicer1CKO) mice.
(D) Immunocytochemistry using antibodies to BrdU and PDGFRa on frozen sections of P14 brains from Olig1CreDicer1lox/+ (Ctrl) mice.
Arrows in (B)–(D) indicate colabeling cells. Scale bars: 100 mm.
(E and F) Histograms depict the quantification of Olig2- and BrdU-expressing cells in P14 brain sections as indicated (n = 3).
(G) Histogram depicts the percentage of BrdU-expressing cells among Olig2-expressing cells in P14 brain sections (n = 3).
Data represent mean ± SEM. *p < 0.001 (Student’s t test).
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partially, to rescue the deficits in oligodendrocyte differentiation
caused by Dicer1 deletion.
miR-219 and miR-338 Induce Oligodendrocyte
Differentiation In Vivo
To examine their in vivo role in oligodendrocyte development, we
first carried out an in ovo gain-of-function study in the embryonic
chick neural tube. Expression vectors for miR-219 and miR-338
were electroporated into the neural tube of E2.5 chick embryos.
The embryos were harvested at E5.5, at which stage the differen-
tiation of endogenous oligodendrocytes had not yet occurred.
Expression of miR-219 and miR-338 from expression vectors
was confirmed by northern blot and in situ hybridization analyses
(Figures S2A and S2B). Overexpression of miR-219 was able to
promote ectopic formation of OPCs expressing PDGFRa or
Olig2 in the electroporated side of neural tube (Figure 5A);
however, we did not observe expression of genes characteristic
of MBP+ mature oligodendrocytes (data not shown). In contrast,
overexpression of miR-338 not only led to ectopic formation ofOPCs expressing Olig2 but also promoted precocious formation
of MBP+ mature oligodendrocytes (Figure 5B). These results
suggest that overexpression of miR-219 and miR-338 promotes
oligodendrocyte specification and differentiation in the chick
neural tube.
The lack of mature oligodendrocyte formation promoted by
miR-219 in the chick neural tube could be due to the difference
in species and/or the cellular context. To determine effects of
miR-219 overexpression on oligodendrocyte development in
mice, we electroporated a miR-219-expressing vector into the
neocortical ventricular zone of developing embryos at E14.5
(Figure 5C). The cortices from electroporated embryos were
collected 3 days later (E17.5), at which stage no MBP+ oligoden-
drocytes can be observed in the cortex. Overexpression of
miR-219 resulted in an increase of Olig2+ and PDGFRa+ OPCs
in the cortex (Figures 5D and S2C). Strikingly, we detected
precocious formation of MBP-expressing cells in the electropo-
rated cortex (Figure 5E). Similar results were also observed in the
cortex with ectopic miR-338 overexpression (Figure 5E). Triple
immunolabeling indicated that the ectopic MBP-expressing cellsNeuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc. 615
Figure 3. Identification of miR-219 and miR-338 as Oligodendrocyte-Specific miRNAs in the Spinal Cord
(A–C) MiRNAs isolated from spinal cord and optic nerve tissues from WT, Dicer1CKO, or Olig1 null mice were subjected to miRNA microarray analysis. The
log2 transformation of relative fold changes in the miRNA expression level from WT versus Dicer1CKO or Olig1KO mice are indicated.
(D) Expression of miR-219 and miR-338 in WT and Olig1 null spinal cord was analyzed by northern blot. U6 RNA is used as a loading control.
(E and F) miR-219 (E) and miR-338 (F) expression was analyzed by qRT-PCR from WT mouse spinal cords at stages indicated (n = 3). U6 RNA was used as internal
control. Data represent mean ± SEM.
(G) Expression of miR-219 and miR-338 was examined in the spinal cord of WT and Olig1KO mice at P14 by in situ hybridization as indicated. Arrows indicate
the miRNA-expressing cells in the white matter region (left part of dashed lines); arrowheads indicate the gray matter. Left panels show lower magnification,
while middle and right panels show higher magnification.
(H and I) Expression of miR-219 and miR-338 was examined in spinal cord of P14 WT mice by in situ hybridization, followed by immunostaining with CC1
and Olig2. Arrows indicate colabeling of miR-219 or miR-338 with oligodendrocyte markers CC1 and Olig2 in the same cells. Scale bars in (G), 100 mm; in (H)
and (I), 50 mm.
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observations suggest that overexpression of either miR-219 or
miR-338 can promote oligodendrocyte formation in the devel-
oping mouse cortex.616 Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc.Knockdown of Endogenous miR-219 and miR-338
Inhibits Oligodendrocyte Maturation
To investigatewhetherendogenousmiR-219ormiR-338 isneces-
sary for oligodendrocyte formation, we treated oligodendrocyte
Figure 4. Enforced miR-219 and miR-338 Expression Promotes Oligodendrocyte Maturation In Vitro
(A and B) Mouse oligodendrocyte precursor-enriched cultures were transfected with miR-219, miR-338(5p+3p) mimics, and scrambled miR control as indicated.
The precursor cells were cultured in oligodendrocyte growth medium for another 4 days and subjected to immunostaining with PDGFRa (blue), RIP (red),
and MBP (green). Scale bars, 50 mm.
(C–E) Histograms depict the percentage of RIP+ (C), MBP+ (D), and PDGFRa+ (E) cells among Olig2+ oligodendrocyte lineage cells, which represents all stages of
oligodendrocytes, in three independent experiments.
(F) Oligodendrocyte precursor-enriched cultures from Dicer1CKO mice were transfected with miR-219, miR-338 (5p+3p) mimics, and scrambled miR control
as indicated. Cells were cultured in oligodendrocyte differentiation medium without mitogens for 3 days and subjected to immunostaining with RIP (red) and
MBP (green). Scale bars, 50 mm.
(G) Histogram depicts the number of MBP+ cells per defined area (0.14 mm2) after miR mimic treatments (n = 3).
Data represent mean ± SEM. *p < 0.01 (one-way ANOVA).
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Figure 5. Ectopic Expression of miR-219 and miR-338 Promotes Precocious Oligodendrocyte Differentiation in Developing Chick Neural
Tube and Embryonic Mouse Cortex
(A and B) Chick neural tubes were electroporated with pCIG expression vectors for miR-219 (A) and miR-338 (B) into the neural tube at E2.5 and harvested at E5.5.
The spinal cord sections were analyzed by in situ hybridization with probes toPdgfra and by immunostaining with antibody against Olig2 or MBP. GFP expression
indicates the electroporated side. Arrows indicate ectopic expression of Pdgfra, Olig2, and MBP detected on the electroporated side of chick neural tubes,
respectively. Scale bars, 100 mm.
(C) Schematic diagram depicts in utero electroporation in the mouse developing cortex at e14.5. Electroporated embryonic cortices (n = 5) were harvested and
analyzed at e17.5, at which stage there endogenous MBP expression is absent.
(D) Quantification of the number of Olig2+ or PDGFRa+ cells on the electroporated cortices (n = 5) at a defined cortical area (0.1 mm2). y axis indicated the ratio of
the number of Olig2+ or PDGFRa+ cells in miR-219- or miR-338-overexpressing cortices to that in the control.
Data represent mean ± SD. *p < 0.05 (one-way ANOVA).
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miRNAs Regulate Oligodendrocyte Differentiationprecursor cultures with miRNA inhibitors to downregulate
miR-219 and miR-338 activities. In contrast to scrambled
control, treatment of miRNA antisense inhibitors for miR-219 or
miR-338 under differentiation condition resulted in significant
reduction of MBP+ oligodendrocyte formation (Figures 6A and
6B). Knockdown of these miRNAs appeared to inhibit oligoden-
drocyte process formation and maturation (Figure 6A). These
observations suggest that inhibition of miR-219 and/or
miR-338 blocks oligodendrocyte differentiation and maturation.
To examine the function of these miRNAs in oligodendrocyte
development in vivo, we chose to examine the knockdown effect
in zebrafish, a model of vertebrates, because the mature se-
quences for these miRNAs are identical between zebrafish and
mouse. We injected antisense morpholino oligonucleotides
(MO) designed to hybridize to miR-219 or miR-338 into Tg(olig2:
egfp) zebrafish embryos, which express EGFP in oligodendro-
cyte lineage cells under control of olig2 regulatory element
(Shin et al., 2003). Embryos injected with either MO developed
normally through 3 days postfertilization (dpf), with few consis-
tent morphological defects. The downregulation of endogenous
miR-219 expression by miR-219MO was verified by northern
blot analysis (Figure 6C). At 3 dpf, dorsally migrated OPCs
were evident in the spinal cord of control larvae, whereas all
miR-219MO-injected larvae (n = 46) had deficits of dorsal
OPCs (Figures 6D and 6E). We confirmed the deficit of OPCs
using Sox10 immunocytochemistry, which revealed an 2-fold
reduction in their number (Figures 6F and 6G). We did not
detect a significant alteration in OPC number or distribution in
miR-338MO-injected larvae (data not shown), which might
reflect a relatively low level of miR-338 in the CNS compared
to miR-219 (Wienholds et al., 2005). Furthermore, formation of
MBP+ mature oligodendrocytes in the dorsal spinal cord was
severely compromised in miR-219MO-injected zebrafish
embryos (Figures 6I and 6J). Significant downregulation of
Mbp, but not the internal control Ef1a, in miR-219MO-injected
embryos was further confirmed by qRT-PCR assay (Figure 6H).
These observations suggest that miR-219 is essential for oligo-
dendrocyte maturation in the zebrafish.
Oligodendrocyte Differentiation Inhibitors
as the Targets of miR-219 and miR-338
To identify potential physiological targets of miR-219 and
miR-338, we performed the analysis of computationally pre-
dicted targets using TargetScan, PicTar, miRanda, and mirBase
prediction algorithms (Bartel, 2009; Grimson et al., 2007; Krek
et al., 2005) to search for evolutionarily conserved targets for
these miRNAs. Despite the lack of sequence homology between
miR-219 and miR-338, both miRNAs were predicted to target
a disproportionately large number of the same genes involved
in negative regulation of oligodendrocyte differentiation (Fig-
ure S3 and Table S2).
Among these targets, we identified Sox6 and Hes5 as known
inhibitors of OPC differentiation. Sox6 is a SRY-box transcription(E) Mouse embryos at e14.5 were electroporated with expression vectors for miR
electroporated cortices were analyzed by immunostaining with antibodies to MB
(F) Triple immunostaining revealed that miR-219- or miR-338-transfected cells ex
cells. Scale bars in (E), 100 mm; in (F), 25 mm.factor that inhibits oligodendrocyte maturation (Stolt et al., 2006).
Hes5 is a member of the bHLH family of transcription factors that
acts as critical downstream effector of the Notch signaling
pathway. It has been shown to inhibit myelin gene expression
and oligodendrocyte differentiation (Kondo and Raff, 2000; Liu
et al., 2006; Wang et al., 1998). Consistent with these findings,
expression of Sox6 was mainly observed in OPCs but not in
differentiated oligodendrocytes (Figures S3C and S3D), which
are enriched with miR-219 and miR-338 (Lau et al., 2008).
We tested Sox6 and Hes5 for miR-219- and miR-338-medi-
ated repression by placing their 30 UTR segments downstream
of a cytomegalovirus (CMV)-driven luciferase reporter and
performed reporter assays in COS7 cells transfected with
expression plasmids for miR-219, miR-338, or a control plasmid
encoding the reverse sequence of corresponding miRNAs.
Overexpression of miR-219 and miR-338 was confirmed by
northern blot analysis with miRNA-specific probes (Figure S2A).
The repression was specifically correlated with the presence of
predicted target sites for these miRNAs (Figure 7A). miR-219
and miR-338 overexpression significantly decreased the lucif-
erase activity of reporters carrying Sox6 or Hes5 30 UTR seg-
ments with their predicted binding sites, respectively (Figures
7B and 7C). Mutation of the ‘‘seed’’ sequence of miR-219 and
miR-338 abolished their repressive activities on the above corre-
sponding luciferase reporters (Figures 7B and 7C). In addition,
mutation of either predicted miR-219 or miR-338 binding sites
in the Sox6 UTR-I or UTR-II segment resulted in a significant
reduction of responses to corresponding miRNA overexpression
(Figures 7D and 7E; data not shown). Thus, the mutagenesis
studies suggest that these predicted binding sites are functional
binding sites at least based on the in vitro assay and that there is
a direct binding of these miRNAs with their targets.
To determine whether expression of Sox6 and Hes5 can be
negatively regulated by miR-219 and/or miR-338, we transfected
primary oligodendrocyte precursor-enriched cultures with
miR-219 and/or miR-338 mimics. Four days after transfection,
total RNAs isolated from control and miRNA-mimic-treated cells
were subject to qRT-PCR measurement. Although the mRNA
level of Sox6 was downregulated 25% and 20% by miR-219
and miR-338 mimics, respectively (Figure 7F), Sox6 protein
expression was reduced significantly 75% after transfection
of miR-219 or miR-338 mimics as shown by western blot analysis
(Figure 7G), suggesting a posttranscriptional inhibition by these
miRNAs. In contrast, mRNA expression of Hes5 was drastically
decreased after treatment of miR-219 or miR-338 mimics (Fig-
ure 7H). In addition, we transfected expression vectors for miR-
219 and miR-338 into adult hippocampal-derived neural progen-
itors and induced them to differentiate into oligodendrocytes with
IGF-1 (Hsieh et al., 2004). Cells transfected with miR-219 or miR-
338 exhibited a substantial reduction of Sox6 and Hes5 expres-
sion compared to control (Figures 7I–7L). Conversely, knock-
down of miR-219 and/or miR-338 by miRNA inhibitors resulted
in an upregulation of Sox6 and Hes5 expression in primary-219, miR-338, and RFP, respectively, and harvested at e17.5. The sections of
P. Arrows indicate the electroporated cells expressing MBP.
press MBP and Olig2 in the electroporated cortices. Arrows indicate colabeling
Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc. 619
Figure 6. Inhibition of miR-219 and miR-338 Blocks Oligodendrocyte Maturation
(A) Purified rat oligodendrocyte precursor cells were transfected with LNA knockdown antisense miRNAs and scrambled control oligonucleotides as indicated
and cultured in oligodendrocyte differentiation medium. Four days after transfection, cultures were subjected to MBP immunostaining.
(B) Histogram depicts the relative number of MBP+ cells per defined area (0.14 mm2) treated with LNA-anti-219 and LNA-anti-338(5p+3p) compared with that
treated with scrambled control oligonucleotide.
(C) Expression of miR-219 in WT and miR-219MO-injected larvae was analyzed by northern blot. U6 RNA is used as loading control.
(D and E) Stereomicroscope images showing a lateral view of living Tg(olig2:egfp) zebrafish larvae at 3 dpf with or without morpholino miR-219 injection. (E) is
shown at larger magnification to show the OPCs in the dorsal spinal cord in control larvae but their absence in the miR-219MO-injected larvae, as indicated
by arrows.
(F) Transverse sections through the spinal cord of larvae at 3 dpf were immunostained with antibody to Sox10. Sox10+ OPCs are indicated by arrows.
(G) Quantification of the average number of Sox10+ OPCs per transverse section in miR-219MO-injected and control zebrafish (n = 46).
(H) qRT-PCR analysis of expression ofmbp and ef1a encoding eukaryotic elongation factor 1 from RNAs isolated from miR-219MO-injected and control zebrafish
(n = 3). rpl13 encoding a ribosomal protein was used as an internal control.
(I and J) In situ hybridization with an mbp probe in zebrafish embryos with or without miR-219MO injection. Arrows in (I) (lateral view) indicate the formation of
mature oligodendrocytes in the dorsal spinal cord. Brackets indicatembp expression in ventral spinal cord. Arrows in (J) (cross-section) indicatembp expression.
Data represent mean ± SEM from three independent experiments. *p<0.01 (one-way ANOVA in B; Student’s t test in G and H). Scale bars in (A), 50 mm; (C and D)
40 mm; (E), 20 mm, (G), 40 mm.
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these observations suggest that expression of Sox6 and Hes5
can be negatively regulated by miR-219 and miR-338.620 Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc.Progression from neural progenitor cells into the oligoden-
droglial lineage requires downregulation of factors directing
other neural cell lineages, such as neurons. Consistent with
Figure 7. miR-219 and miR-338 Target Oligodendrocyte Differentiation Inhibitors
(A) Sequence analysis of 30 UTR of mouse Sox6 and Hes5 transcripts. miR-219, miR-338-5p, and miR-338-3p recognition sites are indicated by red, green,
and blue bars, respectively. Black lines underneath depict the regions (UTR-I or UTR-II) of 30 UTRs that cloned into pMIR-REPORTER: Sox6 30 UTR-I,
863 bp; Sox6 30 UTR-II, 1380 bp; Hes5 30 UTR, 630 bp.
(B and C) Luciferase reporter assays for the effects of expression of miR-219, miR-338-3p, or -5p and their mutant forms with corresponding ‘‘seed’’ sequence
mutations on activities of reporters carrying the 30 UTR segments of Sox6 or Hes5. The histogram shows the ratio of the luciferase activity normalized to control
expression vector carrying the reverse sequence of miR-219 and miR-338-3p and miR-338-5p, respectively.
(D and E) Luciferase reporter assays for the effects of expression of miR-219 and miR-338 on activities of reporters carrying WT and mutant 30 UTR of Sox6 and
Hes5. Sox6-30 UTR-IMu and Sox6-30 UTR-IIMu represent Sox6-30 UTR reporters with mutations of a miR-219 binding site in UTR-I and two miR-338-5p binding
sites in UTR-II, respectively, as shown in (A). The histogram shows the ratio of the luciferase activity normalized to control expression vectors carrying miR-219rev
and miR-338rev, respectively.
(F) qRT-PCR analysis of Sox6 expression from RNAs isolated from mouse primary OPC cultures 4 days after transfection with miR-219, miR-338 (5p+3p) mimics
or both. Scrambled miR transfection was included as control.
(G) Western blot analysis shows that Sox6 protein was downregulated by miR-219 or miR-338 overexpression compared with vector-transfected cells. GAPDH
was included as an internal control.
(H) qRT-PCR analysis of Hes5 expression from RNAs isolated from mouse primary OPC cultures transfected with miR-219, miR-338 (5p+3p) mimics or both.
Scrambled miR transfection was included as control.
(I and J) Expression of Sox6 and Hes5 in rat hippocampal neural precursor cells was examined by immunostaining after 3 days transfection with miR-219- or
miR-338-expressing and control vectors. Arrows indicate the transfected cells. Scale bars, 50 mm.
(K and L) Quantification of Sox6 (K) and Hes5 (L) positive cells among transfected cells (GFP+) from three independent above experiments.
(M and N) qRT-PCR analyses of Sox6 (M) and Hes5 (N) expression using RNAs isolated from mouse primary OPC cultures 4 days after transfection with
LNA-miR-219, LNA-miR-338 (5p+3p) or both knockdown probes as well as the scrambled oligonucleotide control (ctrl) as indicated. Histograms indicated
that knockdown of these miRNAs led to significant upregulation of Sox6 and Hes5. GAPDH was included as an internal control.
Data represent mean ± SEM from three independent experiments. *p < 0.01 (one-way ANOVA).
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known in regulating neuronal differentiation, such as proneuro-
genic factors NeuroD1, Isl1, and Otx2 (Lee et al., 1995;Pfaff et al., 1996; Vernay et al., 2005) (Table S2). Both miR-219
and miR-338 can specifically target to the 30 UTR of Zfp238/
RP58, which is required for cortical neurogenesis (Okado et al.,Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc. 621
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miRNAs Regulate Oligodendrocyte Differentiation2009) (Figure S4). Zfp238 appears to be an inhibitor of oligoden-
drocyte differentiation because overexpression of Zfp238 in
neural progenitor cells repressed expression of Olig2, an essen-
tial factor for oligodendrocyte development, and inhibited forma-
tion of RIP+ mature oligodendrocytes (Figure S4). Collectively,
our data suggest that miR-219 and miR-338 control oligoden-
drocyte maturation by negatively regulating oligodendrocyte
differentiation inhibitors and perhaps proneuronal differentiation
factors.
DISCUSSION
miRNAs Are Important Regulators of Oligodendrocyte
Differentiation and Myelination
Over the past few years, miRNAs have been implicated in many
biological processes. Our work presented here provides
evidence that miRNAs, particularly miR-219 and miR-338, are
critical regulators of oligodendrocyte differentiation and myelina-
tion in the vertebrate CNS. Our studies demonstrate that
miRNAs are not only essential for the formation of myelinating
oligodendrocytes but also sufficient to promote the differentia-
tion from their precursors. These results challenge the view
that miRNAs mainly play fine-tuning roles in developmental
processes (Bartel, 2004; Schratt, 2009; Tsai and Yu, 2009).
Inhibition of miRNA maturation by selectively deleting the
miRNA processing enzyme Dicer1 in oligodendrocyte lineage
cells results in severe myelination deficits in the CNS. In the
absence of Dicer1, oligodendrocyte progenitors exhibit an in-
crease of proliferation, but they fail to further differentiate into
mature myelinating oligodendrocytes. These observations sug-
gest that miRNAs normally inhibit OPC proliferation, while
promoting their differentiation. Thus, miRNAs generated after
Dicer1-mediated processing are the key regulators for the tran-
sition of OPCs into mature myelinating oligodendrocytes.
The significant reduction of Dicer1 expression in the optic
nerve of Dicer1CKO mutants as compared to control mice sug-
gests that the excision of the floxed exon 23 occurred in oligo-
dendrocyte lineage cells mediated specifically by Olig1-Cre. In
addition, it also suggests that a majority of Dicer1 is expressed
in mature oligodendrocytes rather than in their precursors and
other cell types in the optic nerve. This is consistent with data
from cultured oligodendrocytes and OPCs (Figure S1).
The present Dicer1CKO mutant phenotype is perinatal-lethal,
unlike the parallel study from Dugas et al. in which Dicer1flox/
flox;Olig2-Cre mice show a developmental delay but ultimate
recovery of myelination (Dugas et al., 2010 [this issue ofNeuron]).
This apparent discrepancy is most likely the result of differences
in the efficiency of Cre-mediated Dicer1 excision and the differ-
ences of temporal and spatial expression of Cre recombinase
driven by Olig1 and Olig2 promoters as used in our two studies,
respectively. In the Dugas et al. study, the authors observed
a recovery of myelination in the older Dicer1flox/flox;Olig2-Cre
animals, however, they also demonstrated that functional Dicer1
expression in mature oligodendrocytes recovered in these older
animals. The most likely explanation is that the floxed Dicer1
allele is inefficiently removed in cells where Cre expression is
driven by the Olig2 promoter and that the few immature cells in
which Dicer1 expression is not disrupted eventually expand622 Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc.and restore near normal levels of myelin in the older mutant
animals. In the Dicer1CKO mice, we observed a more complete
deletion of Dicer1 expression mediated by Olig1-Cre, which
corresponds with the eventual postnatal lethality of Dicer1CKO
mutant mice.
Oligodendrocyte Differentiation Induced
by miR-219 and miR-338
We show at single-cell resolution that miR-219 and miR-338 are
mainly expressed in CC1+ differentiated oligodendrocytes in the
developing spinal cord. The fact that their expression is essen-
tially absent in the myelin-specific deficient Dicer1 and Olig1
mutant mice supports the notion that these miRNAs are
primarily, if not exclusively, expressed in oligodendrocytes in
the spinal cord. Our in vitro and in vivo functional studies demon-
strate that miR-219 and miR-338 are both necessary and suffi-
cient for oligodendrocyte differentiation, although we do not
exclude the possibility that additional miRNAs may also con-
tribute to oligodendrocyte specification and differentiation.
By manipulating the expression level of miR-219 and miR-338
in oligodendrocyte precursor culture, we found that miR-219 and
miR-338 can promote oligodendrocyte differentiation. The com-
bined treatment of miR-219 and miR-338 mimics promote oligo-
dendrocyte differentiation while resulting in a slight reduction of
the number of PDGFRa+ OPCs, although we did not detect
significant change of the number of PDGFRa+ OPCs treated
with individual miRNA mimics (Figure 4E). The exact reason for
this difference is not clear. Based on in vivo data that both
miR-219 and miR-338 can promote PDGFRa+ OPC formation
from neural progenitors, it is possible that miR-219 and miR-
338 mimics may have an effect on promoting OPC formation
from early progenitors, which may compensate the reduction
of OPCs due to their differentiation into mature oligodendro-
cytes. The treatment of both miR-219 and miR-338 mimics
may have more potent effects than an individual miRNA mimic
on promoting PDGFRa+ OPC differentiation into mature oligo-
dendrocytes. In addition, by introducing miR-219 and miR-338
in OPC cultures derived from Dicer1CKO mice, we observed
that both of miRNAs could compensate, at least partially, for
the defects in oligodendrocyte differentiation due to the loss of
Dicer1, suggesting a crucial role of these miRNAs in promoting
oligodendrocyte maturation.
In developing chick neural tube, ectopic expression of these
miRNAs promotes oligodendrocyte specification from neural
progenitor cells. miR-338 appears to be more potent than
miR-219 in promoting mature oligodendrocyte formation, since
no MBP+ cells were detected in neural tube with ectopic miR-
219 expression. However, overexpression of either miR-219 or
miR-338 is able to promote precocious oligodendrocyte
differentiation in the embryonic mouse cortex, suggesting a
species- or context-dependent function of these miRNAs.
A Critical Role of miR-219 and miR-338
in Oligodendrocyte Maturation
Blocking endogenous activities of miR-219 and miR-338 individ-
ually or in combination inhibits OPC differentiation and matura-
tion in culture. In addition, loss of function of miR-219 results in
an impairment of Olig2+ OPC migration and differentiation in
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drocyte development. Intriguingly, despite the robust activity
of miR-338 in promoting oligodendrocyte differentiation in devel-
oping chick neural tube and embryonic mouse cortex, knock-
down of miR-338 in zebrafish did not have detectable effects
on OPC differentiation. Despite the evolutionary conservation
of miR-338, tissue specificity may have changed in different
species. In zebrafish, miR-338 expression is barely detectable
in the CNS (Wienholds et al., 2005), whereas in mice, miR-338
is mainly expressed in oligodendrocytes in the spinal cord.
Thus, specific cell-type expression or, perhaps, target selection
might also provide an explanation for the major differences of
phenotype observed between zebrafish and mouse.
miR-219 was first described as a clock- and light-regulated
gene that modulates the circadian clock located in the supra-
chiasmatic nucleus in the adult mouse brain (Cheng et al.,
2007). Recently, miR-219 was found to participate in NMDA
receptor signaling by targeting CaMKII gamma to modulate
behavioral responses (Kocerha et al., 2009) and ELOVL7 encod-
ing a lipid synthesis enzyme (Shin et al., 2009). miR-338 is an
intronic miRNA, transcribed together with a host gene encoding
an apoptosis-associated tyrosine kinase (Barik, 2008). It may
participate in neuronal differentiation and function (Kim et al.,
2004; Raghunath et al., 2000). Although miR-219 and miR-338
could be expressed in a population of neurons, we found that
these miRNAs are mainly expressed in oligodendrocytes in the
spinal white matter at postnatal stages. Thus, miR-219 and
miR-338 may have pleiotropic effects on other biological
processes, while promoting oligodendrocyte differentiation in
a context and temporally specific manner.
Downregulation of Differentiation Inhibitors by miRNAs
Is a Critical Event for Oligodendrocyte
Terminal Differentiation
The timing of oligodendrocyte differentiation is controlled by the
balance of activities between positive and negative regulators.
Sox6 and Hes5 could be physiological targets of miR-219 and
miR-338 because both miRNAs have multiple target recognition
sites in their 30 UTR. We validated Sox6 and Hes5 to be bona fide
targets by demonstrating that their expression levels can be
directly controlled by miR-219 and miR-338 through their 30
UTR. Identification of Sox6 and Hes5 as functional targets of
miR-219 and miR-338 is consistent with their inhibitory functions
in oligodendrocyte differentiation (John et al., 2002; Kondo and
Raff, 2000; Liu et al., 2006; Stolt et al., 2006). Loss of Sox6 or
Hes5 in mice results in upregulation of myelin gene expression
(Kondo and Raff, 2000; Liu et al., 2006; Stolt et al., 2006).
Sox6, a member of the SoxD family, competes and counters
the function of SoxE proteins such as Sox10, which promotes
oligodendrocyte terminal differentiation (Stolt et al., 2006).
Notably, Sox6 transcript is mainly present in PDGFRa+ oligo-
dendrocyte precursors, but not in the MBP+ mature oligoden-
drocytes, consistent with its role as a negative regulator of oligo-
dendrocyte maturation (Figure S3). Hes5, another potential
target of these miRNAs, negatively regulates oligodendrocyte
differentiation and myelin gene expression by repressing the
differentiation activators Sox10 and Mash1 (Kondo and Raff,
2000; Liu et al., 2006; Wang et al., 1998).Regulation of differentiation inhibitors by miRNAs suggests a
common theme by which oligodendrocyte differentiation can
be executed through the combinatorial actions of miRNAs and
transcriptional regulators. Unlike proneuronal genes, which are
downregulated after neuronal differentiation, oligodendrocyte
differentiation-promoting factors, including Olig1/2, Sox10, and
MRF (Emery et al., 2009; Wegner, 2008), are normally maintained
in differentiated oligodendrocytes. Our observations suggest
that an active repression of a cohort of differentiation inhibitors
such as Sox6 and Hes5 and perhaps proneuronal differentiation
factors by miRNAs can be one of the critical steps necessary for
allowing OPCs to become terminal differentiated oligodendro-
cytes (Figure 8).
miR-219 and miR-338 may be used in future investigations
as a tool to dissect the details of extracellular and intracellular
pathways that are involved in oligodendrocyte differentiation.
Because both transcriptional and posttranscriptional mecha-
nisms exist for modulating miRNA expression (Bartel, 2004;
Thomson et al., 2006), there is a possibility that a feedback
regulatory loop of Hes5 and Sox6 may exist to regulate the
expression of miR-219 and miR-338, as there are multiple
consensus sites recognized by these transcription factors that
are present in their putative promoter region (data not shown).
The discovery of miRNAs as important modulators of oligo-
dendrocyte differentiation processes can also provide unantici-
pated insights into demyelinating disease mechanisms through
the identification of the cellular effectors of miRNA action. It is
conceivable that the manipulation of specific miRNAs such as
miR-219 and miR-338 might have therapeutic value in promoting
oligodendrocyte remyelination after injury.
EXPERIMENTAL PROCEDURES
Animals, Tissue Processing, and Immunohistochemistry
Olig1-Cre heterozygous mice were crossed with Dicer1lox/lox mice to generate
Olig1Cre+/; Dicerlox/+ mice, which were then bred with Dicer1lox/lox mice
to produce Dicer1CKO offsprings (Olig1Cre+/; Dicerlox/lox). Olig1Cre+/;
Dicerlox/+ mice developed and behaved the same as WT. Dicer1lox/lox mice
were purchased from the Jackson laboratory (strain name: B6.Cg-
Dicer1tm1Bdh/J) (Harfe et al., 2005). All animal use and studies were approved
by the Institutional Animal Care and Use Committee of the University of Texas
Southwestern Medical Center at Dallas, USA, and Sichuan University at
Chengdu, P.R. China.
For immunohistochemistry, mouse brains or spinal cords were short-fixed
1 hr in 4% paraformaldehyde and processed for vibratome-section. For
BrdU pulse labeling, animals were injected intraperitoneally with 100 mg
BrdU/kg body weight 3 hr prior to sacrifice. We used antibodies to Olig2 (gift
of C. Stiles, Harvard Medical School), Sox6 (gift of M. Wegner), PDGFRa
(BD Bioscience, 558774), CC1 (Oncogene Research, OP80), MBP (Covance,
SMI-94R), BrdU (BD Bioscience, 555627), GFAP (Sigma, G3893), and Hes5
(Santa Cruz, sc-13859). Monoclonal antibody to RIP was obtained from the
Developmental Studies Hybridoma Bank at the University of Iowa under the
auspices of the National Institute of Child Health and Human Development.
The protocols of miRNA in situ hybridization and immunostaining following
miRNA in situ hybridization are provided in detail in Supplemental Information.
For electron microscopy, spinal cord and optic nerves were dissected and
fixed in 2% glutaraldehyde and 4% paraformaldehyde in 0.1 M cacodylate
buffer (pH 7.2) for 24 hr and processed as previously described (Xin et al., 2005).
RNA Extraction and qRT-PCR
Total RNAs were purified from tissues or cell cultures using TRizol reagent
according to the manufacturer’s instructions (Invitrogen). RNA was transcribedNeuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc. 623
Figure 8. Schematic Diagram for the Potential Function of miR-219 and miR-338 in Regulating Oligodendrocyte Differentiation
(A) In oligodendrocyte precursor cells (OPCs), mature miRNAs (e.g., miR-219 and miR-338) and their processing enzyme Dicer1 are present at a relatively
low level. The amount of miRNAs in OPCs is not sufficient to repress the expression of oligodendrocyte differentiation inhibitors (e.g., Sox6 and Hes5) and/or
proneuronal differentiation factors (e.g., NeuroD1 and Zfp238), which thereby prevent OPC differentiation.
(B) During oligodendrocyte differentiation, expression of mature miRNAs, particularly miR-219 and miR-338, and Dicer1 increases substantially. miR-219
and miR-338 permit or activate pro-OL factors for oligodendrocyte differentiation and maturation by downregulating a cohort of oligodendrocyte differentiation
inhibitors and repressing genes involved in neuronal differentiation. An important future study would be to identify the molecules that regulate temporal expres-
sion of these miRNAs during oligodendrocyte lineage progression. OPCs, oligodendrocyte precursor cells; OL, oligodendrocytes.
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miRNAs Regulate Oligodendrocyte Differentiationto cDNA with First-Strand cDNA Synthesis Kit (GE Healthcare). Quantitative
real-time PCR was performed using the ABI Prism 7700 Sequence Detector
System (Perkin-Elmer Applied Biosystems), and the relative gene expression
was normalized to internal control such asGapdh orRpl13a. Primer sequences
for SybrGreen probes of target genes are as follows. Mouse Sox6: ‘‘tcagag
caatcaccacaccagaca’’ and ‘‘aaggttgaatgtcagggcaaaggc’’; mouse Hes5:
‘‘tacctgaagcacagcaaagccttc’’ and ‘‘taaagcagcttcatctgcgtgtcg’’; mouse
Dicer1: ‘‘accagcgcttagaattcctgggag’’ and ‘‘gctcagagtccattccttgc’’; mouse
GAPDH: ‘‘gtgtgaaccacgagaaata’’ and ‘‘gttgtcatggatgacctt’’; zebrafish mbp:
‘‘atcttcaacctgggagaaagccga’’ and ‘‘tgcttcccgtccatttcactctct’’; zebrafish
ef1a: ‘‘tcaagcctggtatggttgtgacct’’ and ‘‘acggatgtccttgacagacacgtt’’; zebrafish
rpl13a: ‘‘tcctccgcaagagaatgaacacca’’ and ‘‘tcaaacaccttcagcctgtccaga.’’
miRNA-specific primers were purchased from Applied Biosystems, Inc., and
miRNA qRT-PCR was performed according to manufacturer’s instruction.
miRNA Microarray, Northern Blot, and Western Blot Analyses
miRNAs microarray assays were performed by using a service provider (LC
Sciences). The assay started from 10 mg of total RNA samples on Dual sample
chips with Rodentia miRNA Array based on Sanger miRBase Release 13.0.
For miRNA northern blot analysis, RNA extracted from spinal cord was
electrophoresed on a 20% polyacrylamide (7.6 M urea) gel in 1 3 TBE. Ten
micrograms of RNA was denatured for 5 min at 70C in a buffer containing
50% formamide and 10 mM EDTA (pH 8.0) before loading. After electropho-
resis, RNA was then transferred onto a Zeta probe membrane (Biorad) in
0.53 TBE buffer at 80 V for 1 hr. Hybridization was performed at 37C accord-
ing to a standard protocol. 32P-labeled Star-Fire oligonucleotide probes (IDT)
against mature miR-219, miR-338-5p, and U6 were purified on Sephadex
G-25 microspin columns (BioRad) and used in the hybridization. For western
blot analysis, protein lysates were resolved by SDS-PAGE and blotted using
standard procedures. Antibodies used were as follows: Sox6 (Santa Cruz)
and GAPDH (Abcam). Signals were revealed by using chemiluminescence
with the ECL kit (Pierce) according to the manufacturer’s instruction.
Culture of Rodent Oligodendroglial Precursor Cells and Rat
Hippocampus-Derived Adult Neural Progenitor Cells
For mouse primary OPC-enriched cell cultures, cortical precursors were
isolated from E15.5 as described previously (Chen et al., 2007). Oligodendro-
cyte precursors were enriched in serum-free oligodendrocyte growth medium624 Neuron 65, 612–626, March 11, 2010 ª2010 Elsevier Inc.supplemented with bFGF and PDGF-AA. For miRNA transfection study,
primary OPCs were seeded in 24-well plates in oligodendrocyte growth
medium and transfected with 50 nM of miRNA mimics (Pre-miRNAs, Ambion)
using Lipofectamine 2000 (Invitrogen). A Cy3-labeled scrambled miRNA
(Pre-miR miRNA Precursor Negative Control, Ambion Inc.) transfection was
included as negative control, and the transfection efficiency is >50% in OPC
culture. Four days posttransfection, cultures were harvested for immunocyto-
chemistry and qRT-PCR assay. In knockdown study, OPC-enriched cultures
were transfected with 25 nM miRCURY LNA miRNA knockdown probes
(Exiqon, Vedbaek, Denmark. mmu-miR-219, 139113-04; mmu-miR-338-5p,
139531-04; mmu-miR-338-3p, 139532-04) using Lipofectamine 2000, and
control LNA knockdown probe was included as negative control (Exiqon,
Product # 199002-04). The control knockdown probe has similar probe length
as LNA knockdown probes, and it has no homology to any known miRNA
or mRNA sequences in mouse, rat, or human. Cells were then cultured in
oligodendrocyte differentiation medium without mitogens and four days after
transfection, cultures were harvested for analysis.
Isolation and culture of rat OPCs followed the protocol as previously
described (Chen et al., 2007). The rat hippocampus-derived adult neural
progenitor cells (HCN) were originally isolated from adult female Fisher 344
rats. They give rise to homogeneous populations of oligodendrocytes on
IGF-1 stimulation (Hsieh et al., 2004). The progenitor cells expressed Olig2
when cultured in N2-FGF media (DMEM:F12 with N2 supplement and
bFGF). HCN progenitor cells were grown in N2-FGF media, transfected with
miRNAs or plasmids using Amaxa electroporator according to manufacturer’s
protocol and assayed for immunocytochemistry and qRT-PCR analysis.
miRNA Expression Vectors and Luciferase Reporter Assays
miR-219 locus on chromosome 2 and mir-338 locus on chromosome 11 with
their 200 bp flanking sequences were PCR amplified from mouse genomic
DNA and inserted into pCMV6 vector or pCIG vector (Megason and McMahon,
2002). For generating miRNA mutant constructs, the seeding sequence for
miR-219 was changed from ‘‘GATTG’’ to ‘‘CTAAC,’’ seeding sequences for
miR-338-5p and miR-338-3p were changed from ‘‘ACAAT’’ to ‘‘TGTTA’’ and
from ‘‘CAGCA’’ to ‘‘GTCGT,’’ respectively.
Segments carrying putative miR-219 and miR-338 binding sites in 30 UTR
of Sox6, Hes5, and Zfp238 were cloned into pMIR-REPORT vector (Ambion,
Inc). For mutagenesis of 30 UTR for Sox6, the predicted binding site in
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‘‘GTCGA,’’ the two predicted binding sites in pMir-reporter-Sox6UTR-II for
miR-338-3p was changed from ‘‘ATGCTG’’ to ‘‘GTCGAC’’ and from
‘‘ATGCTG’’ to ‘‘GTCGAC,’’ respectively, by using QuikChange Multi Site-
Directed Mutagenesis Kit (Stratagene, San Diego, CA).
Luciferase reporter constructs were cotransfected with vectors expressing
miRNAs, their reverse sequences (219rev, 338rev) or mutant miRNAs
(219Mu, 338Mu) into COS-7 cells by Lipofectamine 2000. The pRSV-renilla
luciferase plasmid was included as a control for transfection efficiencies.
Luciferase activity was assayed 48 hr after transfection using the dual-lucif-
erase reporter assay system (Promega). At least three transfection assays
were performed to obtain statistically significant data. Statistic analyses
were performed as previously described (Ye et al., 2009).
In Ovo and In Utero Electroporation
Chicken eggs were incubated at 38C. Approximately 1 ml (3 mg/ml) of pCIG
expression vectors carrying mir-219 or miR-338 was injected into a chicken
embryo neural tube at stage HH 13–15 (E2.5) with the aid of Picospritzer III
(Parker Hannifin). In situ hybridization or immunohistochemistry were per-
formed as perviously described (Ye et al., 2009).
For in utero electroporation, DNA solution (2 ml) in PBS containing 0.01%
fast green was injected into the lateral ventricle of the embryos at e14.5. After
injection, electroporation (five 50 ms square pulses of 40 V with 990 ms
intervals) was carried out. Plasmid DNAs (3 mg/ml) used for electroporation
were pCMV-miR219 and pCMV-miR338 and control pRFP. Embryos were
harvested 72 hr after electroporation and processed for immunohistology.
At least five embryos with expression of each transgene were analyzed and
characterized.
Zebrafish Morpholino Injections
Approximately 1 nl of morpholinos at 0.12 mM concentration for miR-219 and
miR-338 (Gene Tools, LLC) was injected individually into Tg(olig2:egfp) zebra-
fish embryos at the one-cell stage. The morpholino sequences used were
miR219: 50-acagatgtccaggcacaattctt gg-30 and miR338: 50-caacaaaatcact-
gatgctggagtg-30. Injected embryos at 3 dpf were paraformaldehyde-fixed,
cryosectioned, and immunostained using an anti-Sox10 antibody or pro-
cessed for in situ RNA hybridization using probe for Mbp.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.neuron.2010.02.018.
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